Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ·Healthcare·Biotechnology
$3.50
-0.14%
Mkt Cap $2.41B
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (9 analysts)
$5.30
Range $5.30 – $5.30
Implied Upside
+51.4%
Consensus $5.30 vs current $3.50
NASDAQ·Healthcare·Biotechnology
$3.50
-0.14%
Mkt Cap $2.41B
Buy
1
Hold
1
Sell
0
Price Target (9 analysts)
$5.30
Range $5.30 – $5.30
+51.4%
Consensus $5.30 vs current $3.50